We are live on ! Find out more
Walleye Trading

Walleye Trading Portfolio holdings

AUM $60B
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
-17.82%
1 Year Est. Return
+42.19%
3 Year Est. Return
+128.08%
5 Year Est. Return
+120.67%
10 Year Est. Return
+788.83%
AUM
$31B
AUM Growth
-$298M
Cap. Flow
+$7.31B
Cap. Flow %
23.57%
Top 10 Hldgs %
20.9%
Holding
6,000
New
759
Increased
2,010
Reduced
1,563
Closed
956

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$105M
2
MSFT icon
Microsoft
MSFT
+$71.3M
3
AMD icon
Advanced Micro Devices
AMD
+$69.9M
4
META icon
Meta Platforms (Facebook)
META
+$63.1M
5
PYPL icon
PayPal
PYPL
+$61.9M

Sector Composition

Rank Sector Weight
1 Technology 3.64%
2 Financials 1.87%
3 Consumer Discretionary 1.24%
4 Healthcare 0.94%
5 Industrials 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVX
5776
PUT
Innovex International
INVX
$1.87B
-1,900
Closed -$71K
SAIH
5777
SAIHEAT Ltd
SAIH
$26.8M
-1,169
Closed -$173K
JBTM
5778
CALL
JBT Marel
JBTM
$7.14B
-1,600
Closed -$190K
JBTM
5779
PUT
JBT Marel
JBTM
$7.14B
-300
Closed -$36K
XYZ
5780
Block Inc
XYZ
$45.9B
-1,149,489
Closed -$105M
SGI
5781
Somnigroup International
SGI
$15.1B
-9,614
Closed -$248K
QVCGA
5782
CALL
DELISTED
QVC Group Inc Series A
QVCGA
-446
Closed -$106K
QVCGA
5783
DELISTED
QVC Group Inc Series A
QVCGA
-1,349
Closed -$321K
QVCGA
5784
PUT
DELISTED
QVC Group Inc Series A
QVCGA
-794
Closed -$189K
TVRD
5785
CALL
Tvardi Therapeutics
TVRD
$23.5M
-297
Closed -$130K
TVRD
5786
Tvardi Therapeutics
TVRD
$23.5M
-284
Closed -$124K
TVRD
5787
PUT
Tvardi Therapeutics
TVRD
$23.5M
-400
Closed -$175K
LGF.A
5788
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-6,600
Closed -$107K
LGF.A
5789
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-3,597
Closed -$58K
LGF.A
5790
PUT
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-100
Closed -$2K
SST.WS
5791
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
-12,480
Closed -$20K
SYRS
5792
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-3,000
Closed -$36K
INFN
5793
DELISTED
Infinera Corporation Common Stock
INFN
-10,844
Closed -$69.4K
BCOV
5794
DELISTED
Brightcove, Inc.
BCOV
-16,434
Closed -$128K
BCOV
5795
PUT
DELISTED
Brightcove, Inc.
BCOV
-3,700
Closed -$29K
SMAR
5796
DELISTED
Smartsheet Inc.
SMAR
-16,203
Closed -$671K
CTLT
5797
DELISTED
CATALENT, INC.
CTLT
-3,088
Closed -$342K
CTLT
5798
PUT
DELISTED
CATALENT, INC.
CTLT
-1,800
Closed -$200K
DNMR
5799
DELISTED
Danimer Scientific, Inc.
DNMR
-310
Closed -$56.3K
LILM
5800
CALL
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
-600
Closed -$2K

Similar funds

Walleye Trading's Q2 2022 Portfolio in Review

As of Q2 2022, Walleye Trading held 6,000 positions worth $31B, down 0.95% from $31.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Walleye Trading deployed $7.31B of net new capital in Q2 2022, opening 759 new positions and adding to 2,010 existing holdings. Its largest new stake was Pfizer: 624,114 shares worth $32.7M.

By sector, the portfolio is most concentrated in Technology at 3.6% of assets, down from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $69.9M trimmed.

  • Walleye Trading's largest Q2 2022 buy was Pfizer: 624,114 shares worth $32.7M.
  • Walleye Trading added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $401M increase.
  • Walleye Trading's biggest Q2 2022 reduction was Advanced Micro Devices, cutting an estimated $69.9M.
  • Walleye Trading fully exited Block Inc in Q2 2022, selling an estimated $105M.
  • Walleye Trading's ten largest holdings make up 21% of its $31B portfolio in Q2 2022.
  • Walleye Trading opened 759 new positions and closed 956 in Q2 2022.
  • Walleye Trading's portfolio value fell 0.95% quarter-over-quarter to $31B.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.